Scientific progress in medicine is accelerating, but getting breakthroughs to patients remains slow and unreliable. Bringing a new drug to market takes 10 to 15 years and costs $2.6 billion on average. Even after FDA approval, too many eligible patients never receive treatment — caught in a system that wasn't built for the complexity of modern medicine. Most promising drugs never make it to market, and those that do reach only a fraction of the patients who could benefit.

Drug discovery is moving faster, but the system that turns it into real-world treatment isn't. We're building the infrastructure to change that.

Forus is embedded into physician workflows, automating all steps between a clinical decision and a patient starting treatment: insurance authorization, financial assistance, and fulfillment routing. We do this for every drug, payer, and pharmacy in the country — free for doctors and patients. By abstracting away complexity, Forus gives doctors the confidence to prescribe the most effective treatments, and patients who used to wait weeks or months are starting treatment in days.

And because Forus plays an unprecedented role in moving prescriptions through the system, our network provides unique insight into where providers get stuck, where patients drop off, and how medicines perform across populations. That perspective helps life sciences companies design better research, launch new therapies more effectively, and invest in harder-to-treat conditions. Five of the top 10 global biopharma companies are already working with Forus.

Forus is used by thousands of medical practices and health systems in all 50 states and is expanding rapidly across specialties. Provider adoption grew 10x year-over-year for the last two years, driven by word of mouth. We already support patients in nearly 80% of U.S. zip codes, including many with complex conditions who are now, for the first time, on treatment that could change the course of their disease.